Cardiovascular Gene Therapy: Past, Present, and Future

This publication has 81 references indexed in Scilit:

• Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials
  Vasa, 2013
• Promoting blood vessel growth in ischemic diseases: challenges in translating preclinical potential into clinical success
  Disease Models & Mechanisms, 2013
• Long-Term Follow-Up Assessment of a Phase 1 Trial of Angiogenic Gene Therapy Using Direct Intramyocardial Administration of an Adenoviral Vector Expressing the VEGF121 cDNA for the Treatment of Diffuse Coronary Artery Disease
  Human Gene Therapy, 2012
• Human Oxidation-Specific Antibodies Reduce Foam Cell Formation and Atherosclerosis Progression
  JACC, 2011
• 10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb
  Gene Therapy, 2011
• Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
  The Lancet, 2011
• Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle
  Gene Therapy, 2011
• VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial
  Molecular Therapy, 2009
• Overexpression of Vascular Endothelial Growth Factor-B in Mouse Heart Alters Cardiac Lipid Metabolism and Induces Myocardial Hypertrophy
  Circulation Research, 2008
• Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
  American Heart Journal, 2007